Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
| dc.contributor.author | Ozbalak, Murat | |
| dc.contributor.author | Akay, Olga Meltem | |
| dc.contributor.author | Pehlivan, Mustafa | |
| dc.contributor.author | Yildiz, Birol | |
| dc.contributor.author | Uzay, Ant | |
| dc.contributor.author | Yigenoglu, Tugce Nur | |
| dc.contributor.author | Elverdi, Tugrul | |
| dc.contributor.author | Kaynar, Leylagul | |
| dc.contributor.author | Ayyildiz, Orhan | |
| dc.contributor.author | Hindilerden, Ipek Yonal | |
| dc.contributor.author | Goksoy, Hasan Sami | |
| dc.contributor.author | Guner, Sebnem Izmir | |
| dc.contributor.author | Gunes, Ahmet Kursad | |
| dc.contributor.author | Sonmez, Mehmet | |
| dc.contributor.author | Yuksel, Meltem Kurt | |
| dc.contributor.author | Bozdag, Sinem Civriz | |
| dc.contributor.author | Ozkurt, Zubeyde Nur | |
| dc.contributor.author | Toptas, Tayfur | |
| dc.contributor.author | Dogu, Mehmet Hilmi | |
| dc.contributor.author | Salim, Ozan | |
| dc.contributor.author | Saydam, Guray | |
| dc.contributor.author | Yavasoglu, Irfan | |
| dc.contributor.author | Ayli, Meltem | |
| dc.contributor.author | Ozet, Gulsum | |
| dc.contributor.author | Albayrak, Murat | |
| dc.contributor.author | Atesoglu, Elif Birtas | |
| dc.contributor.author | Toprak, Selami K. | |
| dc.contributor.author | Yildirim, Rahsan | |
| dc.contributor.author | Mehtap, Ozgur | |
| dc.contributor.author | Besisik, Sevgi Kalayoglu | |
| dc.contributor.author | Nalcaci, Meliha | |
| dc.contributor.author | Altuntas, Fevzi | |
| dc.contributor.author | Ferhanoglu, Burhan | |
| dc.date.accessioned | 2025-10-16T15:18:47Z | |
| dc.date.issued | 2021 | |
| dc.identifier.other | WOS:000691910500283 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/7216 | |
| dc.publisher | CIG MEDIA GROUP, LP | |
| dc.source | CLINICAL LYMPHOMA MYELOMA \& LEUKEMIA | |
| dc.subject | relapsed and refractory | |
| dc.subject | Hodgkin lymphoma | |
| dc.subject | brentuximab vedotin | |
| dc.subject | autologous stem cell transplantation | |
| dc.subject | consolidation | |
| dc.title | Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study | |
| dc.type | Meeting Abstract |
